Contents

Issue 137 • December 2023

In association with

Cover Story

What’s in a name: Agencies struggle to keep up with new drug names

Feature

How gene therapies can transform sickle cell disease treatment

Interview

UK pharma manufacturing prepares for imminent shake up in 2024

In Depth

What’s in a name: Agencies struggle to keep up with new drug names

How gene therapies can transform sickle cell disease treatment

Childproof packaging: How things are changing for consumer drugs

BIO-Europe 2023: Pharma balances on shaky financial and legislative footing

Reform in South Korea means progression in improving time to reimbursement

UK pharma manufacturing prepares for imminent shake up in 2024

Briefing

News in Numbers

Latest News

Latest Deals

Project Updates

Trends & Insight

02/23/2024 23:34:16
  • Home | What's in a name
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Lactalis Ingredients
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Trends & Insight
  • BEA Technologies
  • Natoli
  • In Depth
  • What’s in a name: Agencies struggle to keep up with new drug names
  • How gene therapies can transform sickle cell disease treatment
  • Childproof packaging: How things are changing for consumer drugs
  • BIO-Europe 2023: Pharma balances on shaky financial and legislative footing
  • Reform in South Korea means progression in improving time to reimbursement
  • Q&A: UK pharma manufacturing prepares for imminent shake up in 2024
  • Bio Image Systems
  • Pfanstiehl
  • Listings
  • Events
  • Awards
  • Buyer's Guides
  • Next issue
11/28/2023 00:00:00